mRNA Technologies

mRNA technology demonstrated its enormous potential during the COVID-19 pandemic – not only as a rapid and highly adaptable approach to vaccine development, but also as a promising platform for innovative therapies in oncology, immunology, and personalized medicine. One of the greatest challenges in manufacturing mRNA-based products is preventing the degradation of these sensitive molecules during production, purification, and formulation through to final application. PAN-Biotech provides RNase-free solutions that ensure RNA integrity at every stage of the process – from upstream to downstream – for reliability, consistency, and high-quality results. Our product range covers both upstream and downstream processes: UPSTREAM PROCESSING (USP) - WFI-quality water and RNase-free buffer solutions for in-vitro transcription - Customized enzyme and reagent solutions for efficient synthesis and purification DOWNSTREAM PROCESSING (DSP) - Reagents and buffers for gentle RNA purification - Formulation solutions to stabilisation and storage PAN-Biotech offers high-quality standard products and customized sterile formulations to ensure mRNA integrity and the success of your projects. Our products are also available in small quantities. Our sterile solutions are filled in cGMP quality from 10 L and produced in GMP quality from 25 L.